Clinical Trial

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Name: A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants — clinical trial record (NCT07525947)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-14

Trial Details

NCT Number	NCT07525947
Lead Sponsor	Jade Biosciences, Inc.
Conditions	Healthy Volunteers (HV)
Enrollment	40 participants
Start Date	2026-05-01
Primary Completion	2027-05 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-04